Literature DB >> 28153520

Impact of a procalcitonin-based algorithm on the management of adhesion-related small bowel obstruction.

C Cossé1, C Sabbagh2, V Carroni3, A Galmiche4, L Rebibo3, J-M Regimbeau5.   

Abstract

INTRODUCTION: Adhesion-related small bowel obstruction (ASBO) management is difficult if there are no signs of strangulation or peritonitis when intestinal transit has not been restored. The aim of the present study was to determine the impact of combining a procalcitonin (PCT)-based algorithm with clinical signs on the management of uncomplicated ASBO.
METHOD: We performed a pilot, retrospective, single-center "before-after" study. During the "before" period (2007 to 2012), patients with uncomplicated ASBO (n=93, the Gastrografin® group) underwent a clinical examination and a Gastrografin® index. During the "after" period (2013 to 2016), patients with uncomplicated ASBO (n=70, the algorithm group) underwent a clinical examination and were assessed with the PCT-based algorithm. The study's primary outcome was the appropriateness of ASBO management. The secondary outcomes were the need for surgery and the time to surgery, the LOS, the morbidity and mortality rates, and the recurrence rate.
RESULTS: The proportion of well-managed patients was higher in the algorithm group than in the Gastrografin® group (86% vs. 47%; P<0.001). The time to surgery (48h vs 72h; P=0.02) and the LOS (4 vs. 6days, P=0.02) were significantly lower in the algorithm group. The need for surgery was similar in both groups (31% vs. 37%, P=0.49). The morbidity (P=0.69), mortality (P=0.82) and recurrence rates (P=0.57) were similar in the two groups.
CONCLUSION: The use of a PCT-based algorithm is of value in the routine clinical management of ASBO; it reduces the LOS and the time to surgery without increasing the need for surgery.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Adhesion-related small bowel obstruction; Procalcitonin

Mesh:

Substances:

Year:  2017        PMID: 28153520     DOI: 10.1016/j.jviscsurg.2017.01.004

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  3 in total

1.  Biological scoring system for early prediction of acute bowel ischemia after cardiac surgery: the PALM score.

Authors:  Elie Zogheib; Cyril Cosse; Charles Sabbagh; Simon Marx; Thierry Caus; Marc Henry; Joseph Nader; Mathurin Fumery; Michael Bernasinski; Patricia Besserve; Faouzi Trojette; Cedric Renard; Pierre Duhaut; Said Kamel; Jean-Marc Regimbeau; Hervé Dupont
Journal:  Ann Intensive Care       Date:  2018-04-18       Impact factor: 6.925

2.  Impact of a procalcitonin-based algorithm on the quality of management of patients with uncomplicated adhesion-related small bowel obstruction assessed by a textbook outcome: a multicenter cluster-randomized open-label controlled trial.

Authors:  Charles Sabbagh; Francois Mauvais; Jean-Jacques Tuech; Christophe Tresallet; Pablo Ortega-Debalon; Muriel Mathonnet; Jeremie H Lefevre; Zaher Lakkis; David Fuks; Fabrice Muscari; Bernard Dron; Philippe Couderc; Arnaud Alves; Jean-Marc Regimbeau
Journal:  BMC Gastroenterol       Date:  2022-03-02       Impact factor: 3.067

3.  Predictive Value of Procalcitonin for Infection and Survival in Adult Cardiogenic Shock Patients Treated with Extracorporeal Membrane Oxygenation.

Authors:  Do Wan Kim; Hwa Jin Cho; Gwan Sic Kim; Sang Yun Song; Kook Joo Na; Sang Gi Oh; Bong Suk Oh; In Seok Jeong
Journal:  Chonnam Med J       Date:  2018-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.